Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis

被引：36
|
作者：
Udwadia, Zarir F. [1 ]
Mullerpattan, Jai B. [1 ]
Balakrishnan, Canchi [2 ]
Richeldi, Luca [3 ]
机构：
[1] PD Hinduja Natl Hosp & Med Res Ctr, Dept Resp Med, Veer Savarkar Marg, Bombay 400016, Maharashtra, India
[2] PD Hinduja Natl Hosp & Med Res Ctr, Dept Rheumatol, Bombay, Maharashtra, India
[3] Univ Modena & Reggio Emilia, Dept Resp Med, Ctr Rare Lung Dis, Chair Interstitial Lung Dis, Modena, Italy
来源：
LUNG INDIA | 2015年 / 32卷 / 01期
关键词：
Interstitial lung disease; pirfenidone; systemic sclerosis;
D O I：
10.4103/0970-2113.148451
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Pirfenidone is an anti-fibrotic drug which has been approved for the management of patients with Idiopathic Pulmonary Fibrosis (IPF). However, its role in interstitial lung disease (ILD) due to other causes such as systemic sclerosis (SSc) is not clear. We present a case of a patient with SSc associated ILD who showed a subjective as well as objective improvement in lung function with pirfenidone.
引用
收藏
页码：50 / 52
页数：3
相关论文
共 50 条
  • [31] Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
    Kamenova, Antoniya
    Tzouvelekis, Argyris
    Margaritopoulos, George A.
    FRONTIERS IN MEDICINE, 2023, 10
  • [32] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [33] Efficacy of Cyclophospamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
    Espinosa, Gerard
    Pilar Simeon, Carmen
    Plasin, Miguel Angel
    Xaubet, Antoni
    Munoz, Xavier
    Fonollosa, Vicent
    Cervera, Ricard
    Vilardell, Miguel
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (05): : 239 - 245
  • [34] Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
    Roofeh, David
    Brown, Kevin K.
    Kazerooni, Ella A.
    Tashkin, Donald
    Assassi, Shervin
    Martinez, Fernando
    Wells, Athol U.
    Raghu, Ganesh
    Denton, Christopher P.
    Chung, Lorinda
    Hoffmann-Vold, Anna-Maria
    Distler, Oliver
    Johannson, Kerri A.
    Allanore, Yannick
    Matteson, Eric L.
    Kawano-Dourado, Leticia
    Pauling, John D.
    Seibold, James R.
    Volkmann, Elizabeth R.
    Walsh, Simon L. F.
    Oddis, Chester, V
    White, Eric S.
    Barratt, Shaney L.
    Bernstein, Elana J.
    Domsic, Robyn T.
    Dellaripa, Paul F.
    Conway, Richard
    Rosas, Ivan
    Bhatt, Nitin
    Hsu, Vivien
    Ingegnoli, Francesca
    Kahaleh, Bashar
    Garcha, Puneet
    Gupta, Nishant
    Khanna, Surabhi
    Korsten, Peter
    Lin, Celia
    Mathai, Stephen C.
    Strand, Vibeke
    Doyle, Tracy J.
    Steen, Virginia
    Zoz, Donald F.
    Ovalles-Bonilla, Juan
    Rodriguez-Pinto, Ignasi
    Shenoy, Padmanabha D.
    Lewandoski, Andrew
    Belloli, Elizabeth
    Lescoat, Alain
    Nagaraja, Vivek
    Ye, Wen
    RHEUMATOLOGY, 2023, 62 (05) : 1877 - 1886
  • [35] RITUXIMAB AS RESCUE THERAPY IN ADVANCED PROGRESSIVE SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE
    Kokosi, M.
    Saunders, P.
    Karagiannis, K.
    Chua, F.
    Maher, T. M.
    Renzoni, E. A.
    Wells, A. U.
    THORAX, 2015, 70 : A92 - A92
  • [36] Disease course and outcome of progressive interstitial lung disease in systemic sclerosis
    Hoffmann-Vold, Anna-Maria
    Allanore, Yannick
    Alves, Margarida
    Graf, Nicole
    Airo, Paolo
    Ananyeva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros
    Valentini, Gabriele
    Kowal-Bielecka, Otylia
    Distler, Oliver
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [37] Patient and Physician Perspectives on Systemic Sclerosis-Associated Interstitial Lung Disease
    Cheema, Tariq J.
    Young, Meilin
    Rabold, Erica
    Barbieri, Ashley N.
    Baldwin, Nancy
    Steen, Virginia D.
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2020, 14
  • [38] COMBINATION WITH BOSENTAN AND BERAPROST FOR THE TREATMENT OF PROGRESSIVE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
    Yamasaki, Y.
    Yamada, H.
    Omata, M.
    Ozaki, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S155 - S156
  • [39] Lung Function and Survival in Systemic Sclerosis Interstitial Lung Disease
    Ahmed, Samar Shadly
    Johnson, Sindhu R.
    Meaney, Christopher
    Chau, Cathy
    Marras, Theodore K.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (11) : 2326 - +
  • [40] Effects of Mycophenolate Mofetil on Pulmonary Lung Function in Interstitial Lung Disease of Systemic Sclerosis.
    Pham, Michael
    Griffing, W. Leroy
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S742 - S742
12345